Emergency Department Safety Assessment and Follow-up Evaluation 2
ED-SAFE-2
2 other identifiers
interventional
14,250
1 country
8
Brief Summary
Many patients at risk for suicide are discharged from the ED with little or no intervention. Evidence-based suicide prevention interventions, like universal screening and safety planning should be adopted in clinical practice to help prevent suicidal behavior. This study will test the long-term sustainability of the nurse administered universal screening implemented in the original ED-SAFE study. Also, the investigators will test the impact of a new personalized Safety Planning Intervention guided by Lean has on suicide composite outcomes. The ED-SAFE-2 will use a stepped wedge design where the original eight ED-SAFE sites will collect quantitative and qualitative data during the three phases: Baseline, Implementation, and Maintenance. Using this data, the ED-SAFE-2 will examine both within and between site differences for existing screening practices and new care processes, including safety planning. Most of the data collection on outcomes will be done by retrospective chart review. A Lean Implementation Strategy will be used to ensure that adoption of improved care processes are fully supported vertically and horizontally within the organization, infrastructure is built that supports the efforts, and that the protocols fit naturally within roles, responsibilities, and clinical flow. Consistent with the RFA's emphasis, the intervention target will be the clinician's behavior, including, at minimum, screening and safety planning. All emergency mental health and nursing personnel at the sites will be trained on safety planning, and Lean will be used to help ensure the safety planning is being implemented properly and consistently. The mechanisms of action of the combination of the safety planning training and Lean will be studied, allowing the team to establish both the effect the intervention has on the intervention target but also on the mechanisms of action comprised of departmental culture change and infrastructure support.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2014
Longer than P75 for not_applicable
8 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2014
CompletedFirst Submitted
Initial submission to the registry
April 16, 2015
CompletedFirst Posted
Study publicly available on registry
May 25, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2018
CompletedAugust 7, 2020
August 1, 2020
4.8 years
April 16, 2015
August 6, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Suicide Risk Screening
Consistent with the parent ED-SAFE, a completed suicide screen will be defined as any chart documentation of the presence OR absence of suicidal ideation AND presence or absence of a past suicide attempt (0 = None documented, 1 = Partial (+/- ideation OR attempt noted), 2 = Complete (+/- ideation AND attempt noted). The proportion of general ED patients with a complete screen within each study phase will comprise the primary clinician-level outcome for analyses pertaining to screening (Aim 1). Sensitivity analyses will expand the definition to partial OR complete screens.
up to 4 years
Suicide Risk Detection
Using the parent ED-SAFE criteria, a positive screen (i.e., detection) will be defined as any individual who either endorsed active ideation OR reported a lifetime suicide attempt. The proportion of general ED patients with a positive screen within each study phase will comprise the primary patient-level outcome for analyses pertaining to risk detection.
up to 4 years
Safety Planning & Suicide Composite
We decided that our primary outcome measure should be a broadly defined composite that reflects the subsequent occurrence of significant suicidal behavior/risk. This measure will be defined as the occurrence of any one of the following: (a) suicide, (b) any ED visit or hospitalization related to suicidal ideation or behavior.
6 months after the Index ED Visit
Study Arms (3)
Baseline
NO INTERVENTIONRetrospective Chart Reviews will be conducted for the period between the original ED-SAFE and the new study to test the long-term sustainability of nurse administered universal screening implemented in the original study.
Intervention
OTHER1. Safety Plan Intervention: Clinician training in safety planning, and 2. A Lean Implementation Strategy: The Implementation of the safety planning guided by Lean Combine, this is expected to increase safety planning by clinicians.
Maintenance
NO INTERVENTIONTest sustainability of safety planning during the Maintenance phase.
Interventions
Suicide screen-positive patients who are to be discharged from the ED will receive personalized safety planning by a mental health clinician or nurse
The Safety Planning Intervention will be implemented using Lean performance improvement strategies. Sites will be trained on the Safety Planning Intervention and Lean.
Eligibility Criteria
You may qualify if:
- ED patients \>18 years old
- Seen in ED triage
You may not qualify if:
- patients \<18 years old
- not seen in ED triage
- Adults unable to consent
- Prisoners
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (8)
Maricopa Medical Center
Phoenix, Arizona, 85008, United States
University of Arkansas Medical Center
Little Rock, Arkansas, 72205, United States
University of Colorado Hospital
Aurora, Colorado, 80045, United States
Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02215, United States
Marlborough Hospital
Marlborough, Massachusetts, 01752, United States
University of Nebraska Medical Center
Omaha, Nebraska, 68195, United States
Ohio State Univeristy Medical Center
Columbus, Ohio, 43210, United States
Memorial Hospital of Rhode Island
Pawtucket, Rhode Island, 02860, United States
Related Publications (1)
Boudreaux ED, Larkin C, Vallejo Sefair A, Ma Y, Li YF, Ibrahim AF, Zeger W, Brown GK, Pelletier L, Miller I; ED-SAFE 2 Investigators. Effect of an Emergency Department Process Improvement Package on Suicide Prevention: The ED-SAFE 2 Cluster Randomized Clinical Trial. JAMA Psychiatry. 2023 Jul 1;80(7):665-674. doi: 10.1001/jamapsychiatry.2023.1304.
PMID: 37195676DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Edwin D Boudreaux, PhD
University of Massachusetts, Worcester
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Vice Chair, Director of Research
Study Record Dates
First Submitted
April 16, 2015
First Posted
May 25, 2015
Study Start
January 1, 2014
Primary Completion
October 1, 2018
Study Completion
October 1, 2018
Last Updated
August 7, 2020
Record last verified: 2020-08
Data Sharing
- IPD Sharing
- Will not share